Back
Henry Schein 10K Form
Sell
36
HSIC
Henry Schein
Last Price:
68.99
Seasonality Move:
6.95%
7 Day Trial
ALL ACCESS PASS
$
7
Key Filings
2024-05-07 | 10Q | HSIC/Henry Schein Quarterly |
2024-02-28 | 10K | HSIC/Henry Schein Annual |
2023-11-28 | 10Q | HSIC/Henry Schein Quarterly |
2023-08-07 | 10Q | HSIC/Henry Schein Quarterly |
2023-05-09 | 10Q | HSIC/Henry Schein Quarterly |
2023-02-21 | 10K | HSIC/Henry Schein Annual |
Receive HSIC News And Ratings
See the #1 stock for the next 7 days that we like better than HSIC
HSIC Financial Statistics
Sales & Book Value
Annual Sales: | $12.34B |
---|---|
Cash Flow: | $248M |
Price / Cash Flow: | 18.13 |
Annual Sales: | $27.64 |
Price / Book: | 2.49 |
Profitability
EPS (TTM): | 2.71000 |
---|---|
Net Income (TTM): | $352M |
Gross Margin: | $3.86B |
Return on Equity: | 6.96% |
Return on Assets: | 3.53% |
Henry Schein Earnings Forecast
Key Henry Schein Financial Ratios
- The Gross Profit Margin over the past 30 years for HSIC is 31.29%.
- The Selling, General & Administrative Expenses for HSIC have been equal to 23.96% of Gross Profit Margin.
- The Research & Development expenses have been 0.00% of Revenue.
- The Interest Expense is 20.91% of Operating Income.
- The Net Earning history of HSIC is 3.37% of Total Revenues.
- Per Share Earnings over the last 30 years have been positive in 22 years.
Henry Schein Stock Price Chart
Industry, Sector and Symbol
Stock Exchange: | S&P500 |
---|---|
Industry: | Health Care Providers & Services |
Sector: | Health Care |
Current Symbol: | HSIC |
CUSIP: | 806407 |
Website: | henryschein.com |
Debt
Debt-to-Equity Ratio: | 0.71 |
---|---|
Current Ratio: | 1.55 |
Quick Ratio: | 0.67 |
Price-to-Earnings
Trailing P/E Ratio: | 21.83 |
---|---|
Forward P/E Ratio: | 13.09 |
HSIC Technical Analysis vs Fundamental Analysis
Sell
36
Henry Schein (HSIC)
is a Sell
Is Henry Schein a Buy or a Sell?
-
Henry Schein stock is rated a Sell
The current Henry Schein [HSIC] share price is $68.99. The Score for HSIC is 36, which is 28% below its historic median score of 50, and infers higher risk than normal.